Advisory Research Inc Bridge Bio Pharma, Inc. Transaction History

Advisory Research Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$55.47 - $72.35 $782,182 - $1.02 Million	-14,101 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $166,338 - $308,190	4,334 Added 44.37%	14,101 $1 Million
Q3 2020 Nov 12, 2020	BUY	$27.2 - $42.19 $265,662 - $412,069	9,767 New	9,767 $366,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.